A carregar...
Patient Taking A Novel Oral Anticoagulant Presents With Major GI Bleeding
Novel Oral Anticoagulants (NOACs) such as Dabigatran, Rivaroxaban, Apixaban and Edoxaban are becoming increasingly popular choices for anticoagulation in place of oral Vitamin K Antagonists in various clinical settings. However, they are thought to be associated with an increased risk of gastrointes...
Na minha lista:
| Publicado no: | J Atr Fibrillation |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Cardiofront, Inc
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4955887/ https://ncbi.nlm.nih.gov/pubmed/27957203 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4022/jafib.1218 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|